Revvity
Emilie Eiselt, Ph.D., is an experienced professional in research and development, currently serving as the Research and Development Team Manager at Revvity since December 2019, where the focus is on the development of In Vitro Diagnostic assays and Drug Discovery reagents. Prior to this role, Emilie held the position of Research and Development Project Manager, managing cell signaling projects within the R&D department. Educational qualifications include a Ph.D. in pharmacology from Université de Sherbrooke and a Master's degree in Biology, Health, and Drug Science from Université de Poitiers. Previous work experiences encompass various internships across neuroscience, pharmacology, and preclinical studies, including the development of analgesic drugs at Sarret Pain Lab and studies on receptor functions and muscle protein expressions related to neurodegenerative diseases.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com